To enhance efficiency in drug development, interest in augmenting randomized controlled trials by supplementing the control arm with external data has grown rapidly. However, external data may lack be
These files represent minimal, de-identified, aggregated data used to describe baseline characteristics, our primary outcome, and plot propensity score density curves and cumulative incidence for our